Effects of Nisoldipine on Hypertension and Glomerulosclerosis in Cohen Diabetic Rat with Goldblatt Hypertension

References

• Rosenstock J, Raskin P. Hypertension in diabetes mellitus. Cardiology Clinics 1988; 6: 547–60
   PubMedGoogle Scholar
• Steffes MW, Mauer SM. Diabetic nephropathy: a disease causing and complicated by hypertension. Clin Chemis 1991; 37: 1838–42
   PubMed Web of Science ®Google Scholar
• Reaven PD, Barrett-Connor EL, Browner DK. Abnormal glucose tolerance and hypertesnion. Diabetic Care 1990; 13: 119–25
   PubMed Web of Science ®Google Scholar
• Fuller JH, Stevens LK, The Diabetes Hypertension Study Group. J Human Hyper 1991; 5: 237–43
   PubMed Web of Science ®Google Scholar
• O'Hare JP. Hypertension and prognosis in established diabetic nephropathy. J Human Hypertens 1991; 5: 265–71
   PubMed Web of Science ®Google Scholar
• Hollenberg NK. Strategies in antihypertensive therapy: implications of the kidney. Am J Med 1986; 81(Suppl 6A)15–9
   PubMed Web of Science ®Google Scholar
• Pedrinelli R, Fouad FM, Tarazi RC, et al. Nitrendipine, a calcium-entry blocker. Arch Intern Med 1986; 146: 62–5
   PubMed Web of Science ®Google Scholar
• Ruilope LM. Renal effects of nitrendipine. J Cardiovasc Pharmacol 1991; 18(Suppl 5)S10–3
   PubMedGoogle Scholar
• Andersson OK, Granerus G, Volkmann R, Wysocki M. Hemodynamic and long-term renal effects of felodipine in severely hypertensive patients. J Cardiovasc Pharmacol 1990; 15(Suppl 4)S41
   PubMedGoogle Scholar
• Loutzehiser RD, Epstein M. Calcium antagonists and the kidney. Amer J Hypertens 1989; 2: S154–61
   PubMed Web of Science ®Google Scholar
• Mimran A, Insus A, Ribstein J, et al. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care 1988; 11: 850–3
   PubMed Web of Science ®Google Scholar
• Grossman E, Rosenthal T. The hypotensive effect of nisoldipine in renovascular hypertensive rats. J Hypertens 1986; 4(Suppl 5)S141–4
   PubMedGoogle Scholar
• Gries J, Krezchmar R, Neumann BW. Development of hypertension and life span in stroke-prone spontaneously hypertensive rats during oral long-term treatment with various antihypertensive drugs. J Cardiovasc Pharmacol 1989; 13(Suppl 4)S79–82
   PubMedGoogle Scholar
• Mauer SM, Steffes MW, Azar S, et al. The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 1978; 27: 738–44
   PubMed Web of Science ®Google Scholar
• Jackson B, Cubela R, Debrevi L, et al. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. J Cardiovasc Pharmacol 1978; 10(Suppl 10)S167–69
   Google Scholar
• Whitty MR, Jackson B. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor. Diabetes Research 1988; 8: 91–96
   PubMedGoogle Scholar
• Sato T, Nara Y, Note S, et al. Nifedipine and diltiazem reduced urinary protein excretion. J Cardiovasc Pharmacology 1987; 10(Suppl 10)S192–4
   PubMedGoogle Scholar
• Matsushima Y, Kojima S, Kawmura M, et al. Effects of captopril and nicardipine on renal hyperfiltration and hypertrophy in uninephrectomized diabetic rats. Nippon Jinzo Gakkai Shi (Japanese J Nephrol) 1988; 30: 279–83
   PubMedGoogle Scholar
• Beromiade VC, Lefebvre R, Falardeau P. Unilateral modular diabetic glomerulosclerosis recurrence of an experiment of nature. Am J Nephrol 1987; 7: 55–9
   PubMed Web of Science ®Google Scholar
• Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990; 88: N46–51
   PubMed Web of Science ®Google Scholar
• Cohen AM. Genetically determined responses to different ingested carbohydrates in production of diabetes. Hormone and Metabolic Research 1978; 10: 85–92
   Google Scholar
• Cohen AM, Rosenmann E. Role of genetics, hypertension (Goldblatt kidney) and carbohydrate metabolism disturbance on the development of diabetic nephropathy. Diabetic Nephropathy 1985; 4: 66–72
   Google Scholar
• Mogensen CE. Renal function changes in diabetes. Diabetes 1976; 25(Suppl 2)872–9
   PubMedGoogle Scholar
• Bourgoignie JJ. Progression of Renal disease: current concepts and therapeutic approaches. Kidney International 1992; 41(Suppl)S61–65
   Google Scholar
• Sweeney C, Schultz P, Rau L. Interactions of the endothelium and mesangium in glomerular injury. Am Soc Nephrol 1990; 1(Supp)S13–20
   PubMedGoogle Scholar
• Dworkin LD. Effects of calcium channel blockers on experimental glomerular injury. J Amer Soc Nephrol 1990; 1(Supp)S21–7
   PubMedGoogle Scholar
• Dworkin LD, Parker M, Feiner HD. Nifedipine decreases glomerular injury in rats with remnant kidneys by inhibiting glomerular hypertrophy. Am Soc Nephrol 1988; 21: 279A
   Google Scholar
• Nordlander M, Havu N. Effects of chronic felodipine treatment on renal function and morphology in SHR. Kidney International 1992; 41(Suppl 36)S100–105
   PubMedGoogle Scholar
• Schwietzer G, Wenzel U, Troschau G, Helmchen U, Schoeppe W. Nitrendipine increases albuminuria, glomerular sclerosis and hypertrophy in the contralateral kidney of Goldblatt hypertensive rats (Abstract). J Am Soc Nephrol 1990; 1: 499
   Google Scholar
• Tolins JP, Raij L. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Hypertension 1990; 16: 452–61
   PubMed Web of Science ®Google Scholar
• Berkman J, Rifkin H. Unilateral nodular diabetic glomerulosclerosis (Kimmelsteil-Wilson). Report of a case. Metabolism Clin Exp 1973; 22: 715–22
   PubMedGoogle Scholar
• Anderson S, Brenner BM. Pathogenesis of diabetic glomeruolopathy: hemodynamic considerations. Diabetes Metab Rev 1988; 4: 163–77
   PubMed Web of Science ®Google Scholar